Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
EHA 2025 Congress
2025 ASCO Annual Meeting
2025 ASBrS Annual Meeting
ESTRO 2025
DDW 2025
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
About Us
Advertisement
Advertisement
Advertisement
Jul
03
Today In Oncology
Lean Body Mass–Based Oxaliplatin Dosing and Risk of Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer
FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Relapsed or Refractory Multiple Myeloma
Study Reveals Long-Term Consequences of Chemotherapy on Healthy Blood Cells
Can Hormone Therapy Affect Breast Cancer Risk in Younger Women
Uterine Cancer Incidence and Mortality Rates Projected to Rise Substantially by 2050
View More
Advertisement
